Literature DB >> 35173849

Clinical and prognostic value of CT perfusion imaging parameters in patients with primary liver cancer after therapy.

Yiming Li1, Yuzhou Li1, Yuan Sui1, Guangyao Lin1, Wenqi Huang1, Yinshi Zheng1.   

Abstract

OBJECTIVE: To explore the value of arterial enhancement fraction (AEF) of CT perfusion in evaluating the postoperative treatment efficacy on liver cancer (LC).
METHODS: Clinical data of 60 patients with LC who were treated with transcatheter arterial chemoembolization for LC in our hospital from Jan. 2015 to Jan. 2017 were analyzed retrospectively. They underwent CT scanning before and after surgery. The change of arterial enhancement fraction (AEF) was analyzed, and its value in efficacy evaluation was assessed.
RESULTS: After surgery, the AEF value of the effective group decreased greatly (P<0.05) and was significantly lower than that of the ineffective group (P<0.05). Alpha fetal protein (AFP) of both groups decreased after surgery, with a significantly lower AFP level in the effective group than that in the ineffective group (P<0.05). AEF and AFP were positively correlated. According to the follow-up results, patients with a low AEF level showed a higher survival rate than those with a high level. Cox regression analysis revealed that AEF was an independent factor for patients' prognosis.
CONCLUSION: CT perfusion imaging parameters are of high clinical value for patients with primary LC after therapy and can be used as independent factors for their prognosis. AJTR
Copyright © 2022.

Entities:  

Keywords:  CT perfusion imaging parameters; arterial enhancement fraction; primary liver cancer; prognosis

Year:  2022        PMID: 35173849      PMCID: PMC8829621     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  24 in total

Review 1.  Disease Burden of Hepatocellular Carcinoma: A Global Perspective.

Authors:  Mehmet Sayiner; Pegah Golabi; Zobair M Younossi
Journal:  Dig Dis Sci       Date:  2019-04       Impact factor: 3.199

2.  TACE plus external beam radiotherapy in liver cancer.

Authors:  Manjulika Das
Journal:  Lancet Oncol       Date:  2018-03-23       Impact factor: 41.316

3.  Evaluation of Texture Analysis Parameter for Response Prediction in Patients with Hepatocellular Carcinoma Undergoing Drug-eluting Bead Transarterial Chemoembolization (DEB-TACE) Using Biphasic Contrast-enhanced CT Image Data: Correlation with Liver Perfusion CT.

Authors:  Christopher Kloth; Wolfgang M Thaiss; Rainer Kärgel; Rainer Grimmer; Jan Fritz; Sorin Dumitru Ioanoviciu; Dominik Ketelsen; Konstantin Nikolaou; Marius Horger
Journal:  Acad Radiol       Date:  2017-06-23       Impact factor: 3.173

4.  Hepatocellular carcinoma treated with transarterial chemoembolization: dynamic perfusion-CT in the assessment of residual tumor.

Authors:  Davide Ippolito; Pietro-Andrea Bonaffini; Laura Ratti; Laura Antolini; Rocco Corso; Ferruccio Fazio; Sandro Sironi
Journal:  World J Gastroenterol       Date:  2010-12-21       Impact factor: 5.742

5.  CalliSpheres® drug-eluting beads (DEB) transarterial chemoembolization (TACE) is equally efficient and safe in liver cancer patients with different times of previous conventional TACE treatments: a result from CTILC study.

Authors:  X Zhang; J Zhou; D-D Zhu; J Huang; J-H Sun; T-F Li; C-S Shi; Z-C Sun; Q-M Hou; Z-Y Peng; W-Q Yu; J-S Ji; W-J Gu; G-H Zhou; X-X Xie; X-H Guo; G-H Cao; Z-H Yu; H-H Xu; J Fang; S-H Ying; W-H Hu; W-B Ji; J Han; X Wu; J-P Zheng; J Luo; Y-T Chen; T-Y Hu; L Li; H-J Hu; H-J Du; G-L Shao
Journal:  Clin Transl Oncol       Date:  2018-07-12       Impact factor: 3.405

Review 6.  Hepatocellular carcinoma: From diagnosis to treatment.

Authors:  Miral Sadaria Grandhi; Amy K Kim; Sean M Ronnekleiv-Kelly; Ihab R Kamel; Mounes A Ghasebeh; Timothy M Pawlik
Journal:  Surg Oncol       Date:  2016-03-05       Impact factor: 3.279

7.  Diet and liver cancer risk: a narrative review of epidemiological evidence.

Authors:  Wan-Shui Yang; Xu-Fen Zeng; Zhi-Ning Liu; Qi-Hong Zhao; Yu-Ting Tan; Jing Gao; Hong-Lan Li; Yong-Bing Xiang
Journal:  Br J Nutr       Date:  2020-04-01       Impact factor: 3.718

8.  Value of perfusion parameters and histogram analysis of triphasic computed tomography in pre-operative prediction of histological grade of hepatocellular carcinoma.

Authors:  Chun-Chun Shao; Fang Zhao; Yi-Fan Yu; Lin-Lin Zhu; Guo-Dong Pang
Journal:  Chin Med J (Engl)       Date:  2021-04-14       Impact factor: 2.628

9.  The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level: Results From the Global Burden of Disease Study 2015.

Authors:  Tomi Akinyemiju; Semaw Abera; Muktar Ahmed; Noore Alam; Mulubirhan Assefa Alemayohu; Christine Allen; Rajaa Al-Raddadi; Nelson Alvis-Guzman; Yaw Amoako; Al Artaman; Tadesse Awoke Ayele; Aleksandra Barac; Isabela Bensenor; Adugnaw Berhane; Zulfiqar Bhutta; Jacqueline Castillo-Rivas; Abdulaal Chitheer; Jee-Young Choi; Benjamin Cowie; Lalit Dandona; Rakhi Dandona; Subhojit Dey; Daniel Dicker; Huyen Phuc; Donatus U. Ekwueme; Maysaa El Sayed Zaki; Florian Fischer; Thomas Fürst; Jamie Hancock; Simon I. Hay; Peter Hotez; Sun Ha Jee; Amir Kasaeian; Yousef Khader; Young-Ho Khang; Anil Kumar; Michael Kutz; Heidi Larson; Alan Lopez; Raimundas Lunevicius; Reza Malekzadeh; Colm McAlinden; Toni Meier; Walter Mendoza; Ali Mokdad; Maziar Moradi-Lakeh; Gabriele Nagel; Quyen Nguyen; Grant Nguyen; Felix Ogbo; George Patton; David M. Pereira; Farshad Pourmalek; Mostafa Qorbani; Amir Radfar; Gholamreza Roshandel; Joshua A Salomon; Juan Sanabria; Benn Sartorius; Maheswar Satpathy; Monika Sawhney; Sadaf Sepanlou; Katya Shackelford; Hirbo Shore; Jiandong Sun; Desalegn Tadese Mengistu; Roman Topór-Mądry; Bach Tran; Vasiliy Vlassov; Stein Emil Vollset; Theo Vos; Tolassa Wakayo; Elisabete Weiderpass; Andrea Werdecker; Naohiro Yonemoto; Mustafa Younis; Chuanhua Yu; Zoubida Zaidi; Liguo Zhu; Christopher J. L. Murray; Mohsen Naghavi; Christina Fitzmaurice
Journal:  JAMA Oncol       Date:  2017-12-01       Impact factor: 31.777

Review 10.  Liver Resection and Surgical Strategies for Management of Primary Liver Cancer.

Authors:  Sonia T Orcutt; Daniel A Anaya
Journal:  Cancer Control       Date:  2018 Jan-Mar       Impact factor: 3.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.